Physician profile
Jon H Voss
NPI 1922098177
$2,234.10
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,145 · 2020: $625 · 2021: $401 · 2022: $13.78 · 2023: $49.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $49.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $49.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $494.03 | 2019-2021 | |
| Astellas Pharma US INC | $313.81 | 2019-2021 | |
| Pfizer INC. | $273.72 | 2019-2021 | |
| Duchesnay USA Incorporated | $253.86 | 2019-2020 | |
| Lupin INC. | $123.88 | 2019 | |
| Allergan, INC. | $103.96 | 2020 | |
| Aspira Women'S Health INC | $85.67 | 2021 | |
| Therapeuticsmd, INC. | $78.79 | 2019-2020 | |
| Medical Device Business Services, INC. | $78.07 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.62 | 2019-2021 | |
| Lilly USA, LLC | $48.02 | 2019-2020 | |
| Exeltis, USA INC. | $39.13 | 2020-2021 | |
| Minerva Surgical, INC | $38.65 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.02 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $34.74 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $29.25 | 2021 | |
| Immunogen, INC. | $24.22 | 2023 | Elahere |
| Novo Nordisk INC | $19.53 | 2019 | |
| Baxter Healthcare | $19.15 | 2021 | |
| Ascend Therapeutics US, LLC | $16.50 | 2019 | |
| Coopersurgical, INC. | $13.78 | 2022 | |
| Ethicon US, LLC | $13.35 | 2020 | |
| Evofem Biosciences, INC. | $11.93 | 2021 | |
| Avion Pharmaceuticals | $11.29 | 2019 | |
| Coloplast Corp | $11.27 | 2020 | |
| Ironwood Pharmaceuticals, INC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Voss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.